|
Updated
16:30 IST, 22st April 2003
Molecular
Connections ties up with Triesta to develop biomarkers
EPP
News Bureau - New Delhi
The
Bangalore-based bio-informatics company Molecular Connections and
Triesta Sciences, a clinical genomics company, based in Menlo Park,
CA, have entered into a strategic alliance in the area of biomarker
discovery and validation.
As
a part of the alliance, Molecular Connections will provide its advanced
information extraction, informatics and pathway analysis expertise
for Triesta Sciences’ biomarker discovery program.
"We are very pleased to be working with Triesta in their efforts
to identify novel biomarkers in clinical samples" said Jignesh
Bhate, founder and director of Molecular Connections in a press
communique.
Molecular Connections’ powerful information extraction technologies
and analysis tools help biopharmaceutical scientists to efficiently
navigate, integrate and analyze data from various unstructured and
structured sources.
Molecular
Connections, headquartered in Bangalore, is a joint venture between
Idea2solutions an incubator promoted by the founders of the Dr Reddy’s
group and Laboratories for Information Technology, Singapore, a
national research institute for advanced technologies.
Molecular Connections’ initial focus is to build state-of-the-art
products and provide world-class services to enhance efficiency,
reduce the discovery cycle time and minimize the resources spent
by drug discovery companies. The company utilizes proprietary Natural
Language Processing based tools to extract, curate and annotate
key biomedical information from literature and databases.
Molecular
Connections is currently applying its technology to extract bio-molecular
interactions from literature, particularly protein-protein, gene-drug,
DNA-protein interactions and has developed the most comprehensive
database of protein-protein interactions from literature. It has
offices in Gaithersburg, Maryland and Bangalore, India.
Triesta
BioSciences is a privately owned clinical genomics company based
in Menlo Park, CA and Bangalore, India. Triesta undertakes clinical
and molecular evaluation and validation of new targets and markers
in partnership with international diagnostics and pharmaceutical
companies. Triesta has disease programmes in the areas of oncology,
infectious diseases, gastrointestinal disorders and renal disease.
|
